BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY [Yahoo! Finance]
Bio-Techne Corp (TECH)
Last bio-techne corp earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bio-techne.com
Company Research
Source: Yahoo! Finance
on the discovery and development of innovative medicines targeting microRNAs, today announced continued technical and clinical collaboration following release of Regulus' positive topline results from the second cohort of patients in its Phase 1b MAD (multiple ascending dose) study of RGLS8429 for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). The two companies began the collaboration in 2020 to support Regulus' biomarker analysis for the clinical development of anti-miR-17 therapies for ADPKD treatment. To generate the recently reported topline clinical data for RGLS8429, Regulus utilized Bio-Techne's Simple Western TM platforms and its ExosomeDx CLIA laboratory. Simple Western enables full automation of western blotting for efficient and streamlined workflows to quantify expression and determine size and identity of therapeutic proteins. ExosomeDx, a Bio-Techne brand, is a world leader in developing liquid biopsy-based diagnostics with products and technolo
Show less
Read more
Impact Snapshot
Event Time:
TECH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECH alerts
High impacting Bio-Techne Corp news events
Weekly update
A roundup of the hottest topics
TECH
News
- Declining Stock and Decent Financials: Is The Market Wrong About Bio-Techne Corporation (NASDAQ:TECH)? [Yahoo! Finance]Yahoo! Finance
- Exosome Diagnostics and Therapeutics Market Surges, Anticipated to Hit USD 6,848 Million by 2032 | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Exosomes Development and Manufacturing Market Worth USD 62.8 Billion to 2031- Best Report by InsightAce Analytic Pvt. Ltd. [Yahoo! Finance]Yahoo! Finance
- BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation [Yahoo! Finance]Yahoo! Finance
- BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation [Financial Post (Toronto, Ontario, Canada)]Financial Post
TECH
Earnings
- 5/1/24 - Beat
TECH
Sec Filings
- 5/31/24 - Form SD
- 5/16/24 - Form 4
- 5/14/24 - Form 144
- TECH's page on the SEC website